We are live on ! Find out more
Barclays

Barclays Portfolio holdings

AUM $416B
1-Year Est. Return 33.63%
 

Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.

This Fund
S&P 500
This Quarter Est. Return
-6.74%
1 Year Est. Return
+33.63%
3 Year Est. Return
+104.86%
5 Year Est. Return
+133.18%
10 Year Est. Return
+557.96%
AUM
$82.9B
AUM Growth
-$6.13B
Cap. Flow
+$2.62B
Cap. Flow %
3.16%
Top 10 Hldgs %
28.29%
Holding
7,503
New
382
Increased
2,612
Reduced
3,617
Closed
515

Sector Composition

Rank Sector Weight
1 Healthcare 4.85%
2 Technology 3.93%
3 Financials 3.3%
4 Energy 3.26%
5 Communication Services 2.77%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KALU icon
4426
Kaiser Aluminum
KALU
$2.91B
$118K ﹤0.01%
1,483
-13,065
-90% -$1.09M
RJF icon
4427
CALL
Raymond James Financial
RJF
$34.7B
$118K ﹤0.01%
3,600
+1,650
+85% +$61.2K
BKI
4428
DELISTED
Black Knight, Inc. Common Stock
BKI
$118K ﹤0.01%
3,651
+142
+4% +$4.6K
NAVB
4429
DELISTED
Navidea Biopharmaceuticals Inc.
NAVB
$118K ﹤0.01%
2,933
+2,248
+328% +$84.8K
KERX
4430
PUT
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$118K ﹤0.01%
39,300
-99,300
-72% -$665K
LNN icon
4431
Lindsay Corp
LNN
$1.17B
$117K ﹤0.01%
1,777
-89
-5% -$7.06K
CNCE
4432
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
$117K ﹤0.01%
6,547
+6,159
+1,587% +$105K
GOV
4433
DELISTED
Government Properties Income Trust
GOV
$117K ﹤0.01%
7,331
-17,432
-70% -$295K
CIB icon
4434
Grupo Cibest SA
CIB
$21.4B
$116K ﹤0.01%
3,618
LQD icon
4435
PUT
iShares iBoxx $ Investment Grade Corporate Bond ETF
LQD
$33B
$116K ﹤0.01%
1,000
-2,808,600
-100% -$325M
ODFL icon
4436
PUT
Old Dominion Freight Line
ODFL
$44.8B
$116K ﹤0.01%
5,700
-20,400
-78% -$463K
TKR icon
4437
CALL
Timken Company
TKR
$9.1B
$116K ﹤0.01%
4,300
-900
-17% -$28.7K
UL icon
4438
CALL
Unilever
UL
$139B
$116K ﹤0.01%
2,578
-355
-12% -$17K
ECYT
4439
DELISTED
Endocyte, Inc. Common Stock
ECYT
$116K ﹤0.01%
29,034
+15,531
+115% +$81.3K
BKE icon
4440
PUT
Buckle
BKE
$2.34B
$115K ﹤0.01%
3,200
-4,300
-57% -$181K
IEZ icon
4441
CALL
iShares US Oil Equipment & Services ETF
IEZ
$359M
$115K ﹤0.01%
3,200
+2,200
+220% +$91.5K
IMOS
4442
PUT
ChipMOS TECHNOLOGIES
IMOS
$1.77B
$115K ﹤0.01%
6,534
-3,177
-33% -$62.8K
KPTI icon
4443
Karyopharm Therapeutics
KPTI
$43.3M
$115K ﹤0.01%
773
+739
+2,174% +$198K
OSK icon
4444
PUT
Oshkosh
OSK
$9.43B
$115K ﹤0.01%
3,200
-7,700
-71% -$301K
PRO
4445
DELISTED
PROS Holdings
PRO
$115K ﹤0.01%
5,200
+4,604
+772% +$100K
TRU icon
4446
TransUnion
TRU
$15.3B
$115K ﹤0.01%
4,592
+2,806
+157% +$71.1K
VSAT icon
4447
Viasat
VSAT
$11.2B
$115K ﹤0.01%
1,807
+772
+75% +$47.1K
BEL
4448
PUT
DELISTED
Belmond Ltd.
BEL
$115K ﹤0.01%
11,500
+9,000
+360% +$103K
ARRS
4449
CALL
DELISTED
ARRIS International plc Ordinary Shares
ARRS
$115K ﹤0.01%
4,600
+1,000
+28% +$28.3K
EVEP
4450
PUT
DELISTED
EV Energy Partners, L.P.
EVEP
$115K ﹤0.01%
19,200
+11,100
+137% +$97.1K

Similar funds

Barclays's Q3 2015 Portfolio in Review

As of Q3 2015, Barclays held 7,503 positions worth $82.9B, down 6.9% from $89.1B the previous quarter. Its ten largest holdings account for 28% of the portfolio.

Barclays deployed $2.62B of net new capital in Q3 2015, opening 382 new positions and adding to 2,612 existing holdings. Its largest new stake was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.

By sector, the portfolio is most concentrated in Healthcare at 4.8% of assets, down from 6.6% a quarter earlier, followed by Technology and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $830M trimmed.

  • Barclays's largest Q3 2015 buy was iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019: 3,240,885 shares worth $1.3B.
  • Barclays added most to PRECISION CASTPARTS CORP in Q3 2015, an estimated $281M increase.
  • Barclays's biggest Q3 2015 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $830M.
  • Barclays fully exited DIRECTV COM STK (DE) in Q3 2015, selling an estimated $126M.
  • Barclays's ten largest holdings make up 28% of its $82.9B portfolio in Q3 2015.
  • Barclays opened 382 new positions and closed 515 in Q3 2015.
  • Barclays's portfolio value fell 6.9% quarter-over-quarter to $82.9B.

Based on Barclays's 13F filing for Q3 2015, filed 13 Nov 2015.